Product Images Rilutek
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Rilutek NDC 70515-700 by Covis Pharma Us, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - image 01
Figure 1 - image 02
The text appears to be data from a Kaplan-Meier Survival Curve, depicting the survival probability over time for a placebo group (N=78) and a group taking RILUTEK 50mg twice daily (N=77). The numbers from 10 to 02 indicate time intervals, and the other numbers (excluding "s" and "Figure 1") likely represent survival probabilities for each interval. However, without further context or information, it is difficult to provide a more specific description or interpretation.*
Figure 2 - image 03
The text is a chart titled "Figure 2: Kaplan-Meler Survival Curves" with two lines representing the survival probability. The chart compares the survival probability of a group of 242 individuals receiving placebo compared to 236 individuals receiving RILUTEK 50 mg Twice Daily. No additional information is available to provide further context.*
Logo - image 04
Principal Display Panel - Bottle - image 05
This is a description of a medication called riluzole, which comes in tablet form. A package contains 60 tablets, and the medication should be stored at a controlled room temperature of 20-25°C (68-77°F) and protected from bright light. The medication is made in France and distributed by Coviloz. The rest of the text seems to be nonsensical or unreadable, possibly due to a formatting issue or error.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
